Piper Jaffray assumes Integra LifeSciences coverage — 5 things to know

Piper Jaffray began coverage of Integra LifeSciences shares in a research note issued yesterday, according to a Sleek Monkey report.

Advertisement

Here are five things to know about Integra LifeSciences:

 

1. Piper Jaffray analysts set an “overweight” rating for the stock.
2. Integra traded up yesterday 0.41 percent.
3. Trading volume was 49,458.
4. Integra’s market cap is $1.94 billion.
5. The stock price hit $59.30 with a 52-week high of $61.26.

 

More articles on orthopedic devices:
Medtronic is headed for strong 2015—8 reasons why
5 spine, orthopedic device launches & releases
Lumin Health names two new executives

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Since March 25, there have been two key developments in lawsuits involving spine medtech companies. 1. The U.S. Court of…

  • The highest-paid CFOs at spine and orthopedic medtech companies saw total compensation reaching in the mid-single digits and beyond. Here…

Advertisement

Comments are closed.